×

Please Remove Adblock
Adverts are the main source of Revenue for DoveMed. Please remove adblock to help us create the best medical content found on the Internet.

Pseudobulbar Palsy

Last updated Oct. 19, 2020

Approved by: Krish Tangella MD, MBA, FCAP

Progressive Supranuclear Palsy (PSP) is a rare brain disorder that results in abnormalities in walking, balance, and eye movements. It usually affects adults who are 60 years of age. This neurodegenerative condition is caused by the deterioration of certain brain cells.


The topic Pseudobulbar Palsy you are seeking is a synonym, or alternative name, or is closely related to the medical condition Progressive Supranuclear Palsy.

Quick Summary:

  • Progressive Supranuclear Palsy (PSP) is a rare brain disorder that results in abnormalities in walking, balance, and eye movements. It usually affects adults who are 60 years of age. This neurodegenerative condition is caused by the deterioration of certain brain cells
  • Signs and symptoms associated with Progressive Supranuclear Palsy are problems with balance and frequent falls, stiffness of the body, vision and swallowing difficulties, and mild memory loss (dementia). The diagnosis of PSP includes a complete neurological exam and the use of imaging studies such as MRI scan of the brain
  • The treatment of the disorder may involve medications and supportive therapy, but it cannot be cured. Even though Progressive Supranuclear Palsy is a progressive disorder, the condition generally does not lead to death

Please find comprehensive information on Progressive Supranuclear Palsy regarding definition, distribution, risk factors, causes, signs & symptoms, diagnosis, complications, treatment, prevention, prognosis, and additional useful information HERE.

What are some Useful Resources for Additional Information?


References and Information Sources used for the Article:


Helpful Peer-Reviewed Medical Articles:


Reviewed and Approved by a member of the DoveMed Editorial Board
First uploaded: June 18, 2017
Last updated: Oct. 19, 2020